These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


92 related items for PubMed ID: 4957850

  • 1. Morphologic observations on the effect of antimalarial agents on the erythrocytic forms of Plasmodium berghei in vitro.
    Ladda RL.
    Mil Med; 1966 Sep; 131(9):Suppl:993-1008. PubMed ID: 4957850
    [No Abstract] [Full Text] [Related]

  • 2. [Morphology of the strains of Plasmodium berghei berghei with "acquired" resistance to antimalarial drugs of different chemical groups. I. Morphologic features of strains resistant to derivatives of 4-aminoquinoline and diaminopyrimidine].
    Rabinovich SA.
    Med Parazitol (Mosk); 1969 Sep; 38(3):287-94. PubMed ID: 5396562
    [No Abstract] [Full Text] [Related]

  • 3. Further studies on the effect of antimalarial drugs against erythrocytic forms of Plasmodium gallinaceum in vitro.
    JOSEPHSON ES, TAYLOR DJ, GREENBERG J, COATNEY GR.
    J Infect Dis; 1953 Sep; 93(3):257-62. PubMed ID: 13109240
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative cytochemical study of erythrocytic stages of Plasmodium lophurae Plasmodium berghei.
    Ahr GF.
    Mil Med; 1966 Sep; 131(9):Suppl:1064-70. PubMed ID: 4957812
    [No Abstract] [Full Text] [Related]

  • 5. An in vitro system for screening potential antimalarial drugs.
    Canfield CJ, Altstatt LB, Elliot VB.
    Am J Trop Med Hyg; 1970 Nov; 19(6):905-9. PubMed ID: 4992725
    [No Abstract] [Full Text] [Related]

  • 6. The chemotherapy of rodent malaria. 13. Fine structural changes observed in the eryhrocytic stages of Plasmodium berghei berghei following exposureto primaquine and menoctone.
    Howells RE, Pters W, Fullard J.
    Ann Trop Med Parasitol; 1970 Jun; 64(2):203-7. PubMed ID: 5491874
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The study of antimalarial compounds in vitro.
    Richards WH, Williams SG.
    Br J Pharmacol; 1970 May; 39(1):237P. PubMed ID: 5420128
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.
    Tedlaouti F, Gasquet M, Delmas F, Timon-David P, Madadi NE, Vanelle P, Maldonado J.
    J Pharm Belg; 1990 May; 45(5):306-10. PubMed ID: 2086754
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs.
    Fink E.
    Bull World Health Organ; 1974 May; 50(3-4):213-22. PubMed ID: 4155355
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.